The role of fast approximate estimation displacement forces in prediction of stent-graft-related endoleaks after endovascular abdominal aortic aneurysm repair

快速近似估计位移力在预测腹主动脉瘤腔内修复术后支架移植物相关内漏中的作用

阅读:1

Abstract

BACKGROUND: The flow-induced displacement force (DF) exerted on the stent-graft (SG) by the pulsatile blood flow has been considered a potential cause of sealing failure and endoleaks following endovascular aneurysm repair (EVAR). However, its clinical adoption remains limited by time-consuming computational simulations. This study aimed to validate whether rapid morphology-derived DF parameters, quantified from preoperative imaging, can predict stent-graft-related endoleaks (SGELs). METHODS: In this retrospective case-control study, we analyzed data from 217 patients who underwent EVAR between July 2011 and May 2020. Sixty-nine patients were diagnosed with SGEL while controls (n=148) were matched. DF parameters were derived from preoperative computed tomography angiography (CTA) images using a simplified momentum-based theory. The predictive performance of models integrating DF with oversizing ratio (OSR) was evaluated using area under the curve (AUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). RESULTS: Among 217 patients (mean age 72±8 years; 85% male), 69 (32%) developed SGEL over a median follow-up of 24 months. Higher DF values were independently associated with SGEL [adjusted odds ratio (OR) =2.1; 95% confidence interval (CI): 1.4-3.2; P<0.001]. A model combining DF and OSR achieved superior discrimination (AUC =0.85; 95% CI: 0.80-0.90) compared to traditional anatomical risk factors alone (AUC =0.72; 95% CI: 0.65-0.79; P<0.01), with significant reclassification improvement (NRI =0.613, IDI =0.114; both P<0.001). CONCLUSIONS: Morphology-derived DF parameters, combined with OSR, provide a rapid and reproducible method to predict SGEL after EVAR. This approach may enhance preoperative risk stratification without requiring computationally intensive simulations. Further validation in prospective cohorts is needed to confirm its utility across diverse clinical settings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。